Open-label, Two-part, Dose-escalation and Comparative Pharmacokinetics Study of UB-921 in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- Sponsors United BioPharma
- 15 Sep 2017 Status changed from not yet recruiting to recruiting.
- 03 May 2017 Planned initiation date changed from 1 Jun 2017 to 1 Jul 2017.
- 16 Jan 2017 New trial record